AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10790679 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified logrank tests
Number of subjects: 722
Study 8879472 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron, p.o.
Number of subjects: 12
Study 8879472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1947853 — intervention group
Group type: COMPARATOR
Intervention: Oral alphacalcidol (1 microgram daily) for 6 months
Number of subjects: 0
Study 1947853 — intervention group
Group type: COMPARATOR
Intervention: Intravenous alphacalcidol for 4 months
Number of subjects: 0
Study 1947853 — intervention group
Group type: COMPARATOR
Intervention: Alphacalcidol in euparathyroid subjects
Number of subjects: 0
Study 6830658 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone
Number of subjects: 13
Study 6830658 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirbuterol
Number of subjects: 13
Study 6830658 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone + Isosorbide Dinitrate
Number of subjects: 13
Study 6830658 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirbuterol + Isosorbide Dinitrate
Number of subjects: 13
Study 31481572 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-level care coordination initiative
Number of subjects: 250
Study 31481572 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 250
Study 28985891 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-step method for modular lymphadenectomy (TSMML)
Number of subjects: 270
Study 28985891 — intervention group
Group type: COMPARATOR
Intervention: Conventional method for lymphadenectomy (CML)
Number of subjects: 270
Study 26872076 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar plasma vaporization
Number of subjects: 53
Study 26872076 — intervention group
Group type: COMPARATOR
Intervention: Cold-knife urethrotomy
Number of subjects: 53
Study 25226360 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous ventilation during CPB
Number of subjects: 30
Study 25226360 — intervention group
Group type: COMPARATOR
Intervention: Nonventilated group
Number of subjects: 30
Study 22908151 — intervention group
Group type: EXPERIMENTAL
Intervention: Omadacycline (100 mg i.v. QD, option to transition to 200 mg orally QD)
Number of subjects: 111
Study 22908151 — intervention group
Group type: COMPARATOR
Intervention: Linezolid (600 mg i.v. BID, option to transition to 600 mg orally BID)
Number of subjects: 111
Study 20004445 — intervention group
Group type: EXPERIMENTAL
Intervention: Restricted intravenous fluid regimen adjusted by serum lactate level (group A)
Number of subjects: 299
Study 20004445 — intervention group
Group type: COMPARATOR
Intervention: Restricted intravenous fluid regimen (group R)
Number of subjects: 299
Study 17363763 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent self-construal with promotion focus
Number of subjects: 0
Study 17363763 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdependent self-construal with prevention focus
Number of subjects: 0
Study 17363763 — intervention group
Group type: COMPARATOR
Intervention: Cultural orientation
Number of subjects: 0
Study 17363763 — intervention group
Group type: COMPARATOR
Intervention: Self-construal
Number of subjects: 0
Study 17363763 — intervention group
Group type: COMPARATOR
Intervention: Regulatory focus
Number of subjects: 0
Study 15569656 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibre-supplemented enteral feeding
Number of subjects: 172
Study 15569656 — intervention group
Group type: COMPARATOR
Intervention: No fibre enteral feeding
Number of subjects: 172
Study 12191979 — intervention group
Group type: EXPERIMENTAL
Intervention: Predialysis blood urea nitrogen concentrations peaked in March, coinciding with peak protein catabolic rates, protein and energy intakes.
Number of subjects: 1445
Study 12191979 — intervention group
Group type: EXPERIMENTAL
Intervention: Predialysis systolic and diastolic BP values were highest in winter and lowest in summer.
Number of subjects: 1445
Study 12191979 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean predialysis hematocrit values were highest in July.
Number of subjects: 1445
Study 12191979 — intervention group
Group type: EXPERIMENTAL
Intervention: Thirteen of the 21 variables examined demonstrated statistically significant seasonal components.
Number of subjects: 1445
Study 9784272 — intervention group
Group type: EXPERIMENTAL
Intervention: Grouping strategy (Test 2)
Number of subjects: 16
Study 9784272 — intervention group
Group type: COMPARATOR
Intervention: Control (repeated task without grouping)
Number of subjects: 16
Study 7882110 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance or resistance training exercise classes, 3 times per week for 3 months
Number of subjects: 41
Study 7882110 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 41
Study 2686760 — intervention group
Group type: EXPERIMENTAL
Intervention: DGAVP (des‐glycinamide‐arginine‐8‐vasopressin), 60 IU intranasally
Number of subjects: 13
Study 2686760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 1103205 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 18
Study 1103205 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 18
Study 1103205 — intervention group
Group type: EXPERIMENTAL
Intervention: Benztropine
Number of subjects: 18
Study 31078482 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8399
Study 31078482 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399
Study 27045739 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session health counseling
Number of subjects: 168
Study 27045739 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session health counseling and three months of weekly structured group exercise training
Number of subjects: 168
Study 27045739 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 168
Study 25956283 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 1000 IU/day orally
Number of subjects: 160
Study 25956283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 23216868 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention
Number of subjects: 165
Study 16828477 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg daily for 21 days)
Number of subjects: 30
Study 16828477 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen (2 mg daily for 21 days)
Number of subjects: 30
Study 16828477 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen+Progestagen (2 mg E(2) + 5 mg medroxyprogesterone acetate daily for 21 days)
Number of subjects: 30
Study 16828477 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hormonal treatment)
Number of subjects: 30
Study 12492794 — intervention group
Group type: COMPARATOR
Intervention: Epidural block with 15 ml of 0.5% bupivacaine
Number of subjects: 30
Study 12492794 — intervention group
Group type: EXPERIMENTAL
Intervention: Psoas compartment block with 30 ml of 0.5% bupivacaine
Number of subjects: 30
Study 11699358 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 10
Study 11699358 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil
Number of subjects: 10
Study 8784087 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone 200 mg
Number of subjects: 25
Study 8784087 — intervention group
Group type: EXPERIMENTAL
Intervention: Troglitazone 400 mg
Number of subjects: 25
Study 8784087 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and weight-matched ovulatory women)
Number of subjects: 25
Study 1458664 — intervention group
Group type: EXPERIMENTAL
Intervention: Amorolfine nail lacquer 2%
Number of subjects: 157
Study 1458664 — intervention group
Group type: EXPERIMENTAL
Intervention: Amorolfine nail lacquer 5%
Number of subjects: 157
Study 6321311 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ranitidine
Number of subjects: 6
Study 6321311 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 6
Study 30999886 — intervention group
Group type: EXPERIMENTAL
Intervention: Home smartphone urinalysis test (Dip.io)
Number of subjects: 999
Study 30999886 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 999
Study 27917729 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical triamcinolone
Number of subjects: 40
Study 27917729 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dapsone
Number of subjects: 40
Study 27917729 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tacrolimus
Number of subjects: 40
Study 27917729 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinoid
Number of subjects: 40
Study 25817226 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal eGFR
Number of subjects: 1094
Study 25817226 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex, younger age (<65 years), higher baseline proteinuria
Number of subjects: 1094
Study 22872427 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline and hydroxyethyl starch (Voluven®) dissolved in normal saline (saline)
Number of subjects: 36
Study 22872427 — intervention group
Group type: COMPARATOR
Intervention: Balanced crystalloid and colloid solutions (Ringerfundin® and Tetraspan®)
Number of subjects: 36
Study 21888632 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline survey prior to a planned cluster randomised intervention
Number of subjects: 7854
Study 21888632 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of Balanta ethnic group
Number of subjects: 7854
Study 21888632 — intervention group
Group type: EXPERIMENTAL
Intervention: Fula children
Number of subjects: 7854
Study 21888632 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing walking distance to the nearest health centre
Number of subjects: 7854
Study 21888632 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygyny
Number of subjects: 7854
Study 19425821 — intervention group
Group type: EXPERIMENTAL
Intervention: DanShen (Salvia miltiorrhizae)
Number of subjects: 150
Study 17568837 — intervention group
Group type: EXPERIMENTAL
Intervention: Light polymerization of both the adhesive and resin cement in G-2
Number of subjects: 40
Study 17568837 — intervention group
Group type: COMPARATOR
Intervention: G-2 (opaque post)
Number of subjects: 40
Study 17568837 — intervention group
Group type: COMPARATOR
Intervention: Autopolymerized adhesive in G-4
Number of subjects: 40
Study 17568837 — intervention group
Group type: COMPARATOR
Intervention: Middle and apical post/root regions
Number of subjects: 40
Study 15510807 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 46
Study 15510807 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 46
Study 11158015 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal estradiol and progesterone replacement
Number of subjects: 30
Study 11158015 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hormone treatment)
Number of subjects: 30
Study 10023313 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose radiotherapy (59.4 Gy in 6.5 weeks)
Number of subjects: 0
Study 10023313 — intervention group
Group type: COMPARATOR
Intervention: Low-dose radiotherapy (45 Gy in 5 weeks)
Number of subjects: 0
Study 7600396 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoral technique
Number of subjects: 10
Study 7600396 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous technique
Number of subjects: 10
Study 3289874 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanid/Captopril
Number of subjects: 15
Study 3289874 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanid/Urapidil
Number of subjects: 15
Study 3289874 — intervention group
Group type: EXPERIMENTAL
Intervention: Acebutolol/Piretanid
Number of subjects: 15
Study 31568905 — intervention group
Group type: EXPERIMENTAL
Intervention: GUIDETM-assisted DBS programming
Number of subjects: 10
Study 31568905 — intervention group
Group type: COMPARATOR
Intervention: Traditional trial-and-error DBS programming
Number of subjects: 10
Study 28362135 — intervention group
Group type: EXPERIMENTAL
Intervention: cIPV-bOPV-bOPV (I-B-B)
Number of subjects: 600
Study 28362135 — intervention group
Group type: EXPERIMENTAL
Intervention: cIPV-cIPV-bOPV (I-I-B)
Number of subjects: 600
Study 28362135 — intervention group
Group type: EXPERIMENTAL
Intervention: All vaccination schedules
Number of subjects: 600
Study 26422874 — intervention group
Group type: EXPERIMENTAL
Intervention: esmolol 1 mg/kg
Number of subjects: 81
Study 26422874 — intervention group
Group type: EXPERIMENTAL
Intervention: lidocaine 1.0 mg/kg
Number of subjects: 81
Study 26422874 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (Control)
Number of subjects: 81
Study 22921270 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline body dissatisfaction in girls
Number of subjects: 88
Study 22921270 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline body dissatisfaction in boys
Number of subjects: 88
Study 20812949 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent recombinant interleukin-2 (rIL-2) with cART
Number of subjects: 179
Study 20812949 — intervention group
Group type: COMPARATOR
Intervention: cART alone (control arm)
Number of subjects: 179
Study 20812949 — intervention group
Group type: EXPERIMENTAL
Intervention: rIL-2 received <180 days previously
Number of subjects: 179
Study 20812949 — intervention group
Group type: EXPERIMENTAL
Intervention: rIL-2 received ≥180 days previously
Number of subjects: 179
Study 20812949 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 arm over time
Number of subjects: 179
Study 19924605 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose pioglitazone (15 mg/day)
Number of subjects: 50
Study 19924605 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose metformin (500 mg/day)
Number of subjects: 50
Study 16824993 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine (LDD) infusion (7.5 microg/kg/min)
Number of subjects: 20
Study 16824993 — intervention group
Group type: COMPARATOR
Intervention: Resting parameters
Number of subjects: 20
Study 15297687 — intervention group
Group type: COMPARATOR
Intervention: Wheat grass juice (100 mL daily)
Number of subjects: 16
Study 10708231 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol maleate
Number of subjects: 45
Study 10708231 — intervention group
Group type: COMPARATOR
Intervention: 2% carteolol
Number of subjects: 45
Study 10708231 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3% metipranolol
Number of subjects: 45
Study 10708231 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments (timolol maleate, carteolol, metipranolol)
Number of subjects: 45
Study 9496201 — intervention group
Group type: EXPERIMENTAL
Intervention: McCoy blade
Number of subjects: 22
Study 9496201 — intervention group
Group type: COMPARATOR
Intervention: Macintosh blade
Number of subjects: 22
Study 8455366 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive diabetes treatment
Number of subjects: 1441
Study 8455366 — intervention group
Group type: COMPARATOR
Intervention: AER > or = 28 micrograms/24 hr
Number of subjects: 1441
Study 8455366 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratification of all subjects in the secondary cohort
Number of subjects: 1441
Study 3540874 — intervention group
Group type: EXPERIMENTAL
Intervention: Amfenac 100 mg
Number of subjects: 120
Study 3540874 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 600 mg
Number of subjects: 120
Study 3540874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 31286908 — intervention group
Group type: EXPERIMENTAL
Intervention: SUPA intervention + usual care
Number of subjects: 372
Study 31286908 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 372
Study 29771568 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate rewards (Study 1)
Number of subjects: 0
Study 29771568 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate bonus (Study 2)
Number of subjects: 0
Study 29771568 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate bonus (Study 3)
Number of subjects: 0
Study 29771568 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate rewards (Study 4)
Number of subjects: 0
Study 29771568 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of rewards (Study 5)
Number of subjects: 0
Study 26739976 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 mg/kg rocuronium based on corrected body weight (CBW)
Number of subjects: 40
Study 26739976 — intervention group
Group type: COMPARATOR
Intervention: 1.2 mg/kg rocuronium based on lean body weight (LBW)
Number of subjects: 40
Study 24986568 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-acting oral anticoagulants (DOACs)
Number of subjects: 71683
Study 24986568 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 71683
Study 21967443 — intervention group
Group type: EXPERIMENTAL
Intervention: Light effort
Number of subjects: 12
Study 21967443 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate effort
Number of subjects: 12
Study 21967443 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous wheeling mode
Number of subjects: 12
Study 21967443 — intervention group
Group type: EXPERIMENTAL
Intervention: Stop-go wheeling mode
Number of subjects: 12
Study 19860554 — intervention group
Group type: EXPERIMENTAL
Intervention: 38% hydrogen peroxide bleaching
Number of subjects: 56
Study 19860554 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft drink immersion
Number of subjects: 56
Study 19860554 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated toothbrushing with whitening dentifrice
Number of subjects: 56
Study 19860554 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft drink immersion and bleaching
Number of subjects: 56
Study 19860554 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft drink immersion, bleaching, and toothbrushing
Number of subjects: 56
Study 19860554 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleaching and toothbrushing
Number of subjects: 56
Study 19860554 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 56
Study 18594373 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine
Number of subjects: 31
Study 18594373 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 31
Study 15662233 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 129
Study 15662233 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 129
Study 11843308 — intervention group
Group type: EXPERIMENTAL
Intervention: Goodknight 418A (Malinckrodt, Nancy, France)
Number of subjects: 12
Study 11843308 — intervention group
Group type: COMPARATOR
Intervention: Virtuoso LX (Respironics, Nantes, France)
Number of subjects: 12
Study 10552992 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential antimicrobial therapy (SAT)
Number of subjects: 89
Study 8916465 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoarthritic femoral heads
Number of subjects: 12
Study 8916465 — intervention group
Group type: COMPARATOR
Intervention: Control femoral heads
Number of subjects: 12
Study 1757612 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% halobetasol ointment
Number of subjects: 204
Study 1757612 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 204
Study 6184729 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulprostone (500 micrograms administered i.m. every four or six hours)
Number of subjects: 26
Study 31736082 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped-care treatment starting with 14 weekly sessions of manualized CBT
Number of subjects: 269
Study 31736082 — intervention group
Group type: COMPARATOR
Intervention: Prolonged CBT
Number of subjects: 269
Study 31736082 — intervention group
Group type: COMPARATOR
Intervention: SSRIs
Number of subjects: 269
Study 31227777 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training program for 3 months
Number of subjects: 0
Study 31227777 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 28972790 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 150
Study 28972790 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 150
Study 28972790 — intervention group
Group type: COMPARATOR
Intervention: Right decubitus position
Number of subjects: 150
Study 25858974 — intervention group
Group type: EXPERIMENTAL
Intervention: TFRL IMT
Number of subjects: 20
Study 25858974 — intervention group
Group type: COMPARATOR
Intervention: MTL IMT
Number of subjects: 20
Study 23363616 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical activity and nutrition program
Number of subjects: 478
Study 23363616 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 478
Study 21185507 — intervention group
Group type: EXPERIMENTAL
Intervention: GTN plus atorvastatin (80 mg/day)
Number of subjects: 36
Study 21185507 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg/day) alone
Number of subjects: 36
Study 21185507 — intervention group
Group type: COMPARATOR
Intervention: GTN plus placebo
Number of subjects: 36
Study 19093336 — intervention group
Group type: EXPERIMENTAL
Intervention: 21-gene assay (Oncotype DX)
Number of subjects: 0
Study 19093336 — intervention group
Group type: EXPERIMENTAL
Intervention: 70-gene assay (MammaPrint)
Number of subjects: 0
Study 16507846 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple aspiration
Number of subjects: 137
Study 16507846 — intervention group
Group type: COMPARATOR
Intervention: Tube thoracostomy
Number of subjects: 137
Study 12045127 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifapentine 600 mg plus isoniazid (INH)
Number of subjects: 150
Study 12045127 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifapentine 900 mg plus isoniazid (INH)
Number of subjects: 150
Study 12045127 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifapentine 1,200 mg plus isoniazid (INH)
Number of subjects: 150
Study 12045127 — intervention group
Group type: COMPARATOR
Intervention: Control: Twice-weekly rifampin plus isoniazid (not explicitly detailed in the abstract)
Number of subjects: 150
Study 9665011 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandimmun Neoral (SN) with Phenihydine, n = 20
Number of subjects: 42
Study 9665011 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandimmun Neoral (SN) without Phenihydine, n = 12
Number of subjects: 42